Главная    Ex Libris    Книги    Журналы    Статьи    Серии    Каталог    Wanted    Загрузка    ХудЛит    Справка    Поиск по индексам    Поиск    Форум   
blank
Авторизация

       
blank
Поиск по указателям

blank
blank
blank
Красота
blank
Nathanson N. (ed.), Ahmed R., Brinton M.A. — Viral Pathogenesis and Immunity
Nathanson N. (ed.), Ahmed R., Brinton M.A. — Viral Pathogenesis and Immunity



Обсудите книгу на научном форуме



Нашли опечатку?
Выделите ее мышкой и нажмите Ctrl+Enter


Название: Viral Pathogenesis and Immunity

Авторы: Nathanson N. (ed.), Ahmed R., Brinton M.A.

Аннотация:

Introductory textbook for graduate students and trainees. Treats all aspects of infection of the animal host with emphasis on mechanisms explaining the complex interaction between parasite and host. Keeps only to the essentials. Softcover. DNLM: Viruses — pathogenicity.


Язык: en

Рубрика: Медицина и здравоохранение/

Статус предметного указателя: Готов указатель с номерами страниц

ed2k: ed2k stats

Год издания: 2001

Количество страниц: 220

Добавлена в каталог: 01.12.2006

Операции: Положить на полку | Скопировать ссылку для форума | Скопировать ID
blank
Предметный указатель
Sex differences, virus susceptibility      168
Shedding, virus, environmental survival of shed virus      22
Shedding, virus, fluids      22
Shedding, virus, gastrointestinal tract      21
Shedding, virus, mucous membrane      22
Shedding, virus, oropharynx      21
Shedding, virus, respiratory tract      21—22
Shedding, virus, skin      22
Simian immunodeficiency virus (SIV), antigenic variants      122—123
Simian immunodeficiency virus (SIV), cell killing in vitro      173—174
Simian immunodeficiency virus (SIV), cell killing in vivo      174
Simian immunodeficiency virus (SIV), cellular immune response      177
Simian immunodeficiency virus (SIV), clearance      94f
Simian immunodeficiency virus (SIV), comparative pathogenesis of virulent and attenuated viruses      108
Simian immunodeficiency virus (SIV), glycosylation and immune response      206 206t
Simian immunodeficiency virus (SIV), human immunodeficiency virus chimera, tropism      36—37 36f
Simian immunodeficiency virus (SIV), human immunodeficiency virus chimera, vaccination studies      204—206 208f
Simian immunodeficiency virus (SIV), humoral immune response      177 206f
Simian immunodeficiency virus (SIV), kinetics of infection      179f
Simian immunodeficiency virus (SIV), nonpathogenic infection      180—182
Simian immunodeficiency virus (SIV), persistence      119 122—123
Simian immunodeficiency virus (SIV), species susceptibility      171
Simian immunodeficiency virus (SIV), spread of infection      174
Simian immunodeficiency virus (SIV), strain effects on immunosuppression      93—94
Simian immunodeficiency virus (SIV), susceptibility factors      165f
Simian immunodeficiency virus (SIV), vaccination      205f 206f 208f
Simian immunodeficiency virus (SIV), viral set point      205f
Simian immunodeficiency virus (SIV), virulence and long-term infection      18 If
Sindbis virus, age effects on susceptibility      166
Sindbis virus, apoptosis induction      47
SIV      See Simian immunodeficiency virus
Skin, entry of viruses      13—15 15t
Skin, shedding of viruses      22
Skin, structure      12—13
Smoldering infection, definition      120
Smoldering infection, diseases      128
Smoldering infection, persistence mechanisms, antigenic variation      121—123
Smoldering infection, persistence mechanisms, cytotoxic T lymphocyte impairment      121
Smoldering infection, persistence mechanisms, immune-privileged sites      120—121
Smoldering infection, persistence mechanisms, infectious immune complexes      121
Smoldering infection, persistence mechanisms, intercellular bridges      121
Smoldering infection, persistence mechanisms, major histocompatibility complex class I suppression      121
Spallanzani, Lazaro      3
Spread, viruses, blood to tissue spread      19—20
Spread, viruses, human immunodeficiency virus      174
Spread, viruses, local spread      17
Spread, viruses, neural spread      20—21
Spread, viruses, viremia, cell-associated viremia      19
Spread, viruses, viremia, phases      17
Spread, viruses, viremia, plasma viremia      18
Spread, viruses, viremia, sources      18
Src, cellular homolog discovery      10s
Src, viral oncogene      134
SSPE      See Subacute sclerosing panencephalitis
St. Louis encephalitis virus, age effects on susceptibility      167—168
SU, CD4 binding      171 172f 177
Subacute sclerosing panencephalitis (SSPE), incidence      127
Subacute sclerosing panencephalitis (SSPE), intercellular bridges in persistence      121
Subacute sclerosing panencephalitis (SSPE), measles virus persistence      127 127f
Susceptibility, age factors      166s
Susceptibility, age factors, infancy      165—167 166f 167t
Susceptibility, age factors, old age      167—168 167f
Susceptibility, human immunodeficiency virus, AIDS resistance      164—165
Susceptibility, human immunodeficiency virus, HLA-B57 in AIDS susceptibility      165
Susceptibility, human immunodeficiency virus, infection resistance      164
Susceptibility, mouse models, avian leukosis-sarcoma viruses      162
Susceptibility, mouse models, Flv with flavivirus infection      160—161 161t 162f
Susceptibility, mouse models, loci in mouse strains      160t
Susceptibility, mouse models, lymphocytic choriomeningitis virus      162—163
Susceptibility, mouse models, mouse hepatitis virus receptors      162
Susceptibility, mouse models, murine leukemia virus      161—164
Susceptibility, mouse models, Mx role with influenza virus infection      159—160 161f
Susceptibility, mouse models, overview      158—159
Susceptibility, mouse models, receptors      163t
Susceptibility, mouse models, strain susceptibility      159t 160f 161t 162f
Susceptibility, pregnancy      168
Susceptibility, prospects for study      168
Susceptibility, sex differences      168
Susceptibility, undernutrition      168
SV40, oncogenesis, tumor suppressor protein inactivation      143
Syncytium, virus production      39 39f
T cell      See also CD4 lymphocyte; CD8 lymphocyte
T cell receptor (TCR), ligand binding      57 58
T cell receptor (TCR), structure      57
T cell, assays      64t
T cell, assays, chromium-51 release assay      63f: 64
T cell, assays, ELISPOT      65
T cell, assays, fluorescence-activated cell sorting      64—65
T cell, assays, limiting dilution assay      63—64
T cell, immune response overview      57 60f
T cell, kinetics of response      66f
T cell, maturation      56 58—59
T cell, mucosal immune response      67—68
T cell, protection against reinfection      66
T cell, recovery from initial infection      66
T cell, specificity of response      57—58
T cell, virus response, overview      48 117
TCR      See T cell receptor
Theiler's murine enephalomyelitis virus (TMEV), classification      126
Theiler's murine enephalomyelitis virus (TMEV), persistence mechanisms      126 126t
TMEV      See Theiler's murine enephalomyelitis virus
TMV      See Tobacco mosaic virus
TNF      See Tumor necrosis factor
Tobacco mosaic virus (TMV), history of study      5
Tolerance, high-titer persistent infections and immune tolerance, lytic viruses      119
Tolerance, high-titer persistent infections and immune tolerance, nonlytic viruses      117—119
Tolerance, lymphocytic choriomeningitis virus induction      85—86
Tolerance, virus induction features      18 84
Transcription, virus modulation      40—41
Translation, virus modulation      41—2
Transmission, virus entry sites, gastrointestinal tract      15—16
Transmission, virus entry sites, modes      22
Transmission, virus entry sites, oropharynx      15—16
Transmission, virus entry sites, respiratory tract      16—17
Transmission, virus entry sites, skin and mucous membrane      12—15
Transmission, virus entry sites, transcutaneous injection      15
Transmission, virus entry sites, urogenital tract      15
Tropism, cellular receptor, glycoprotein receptors      27—28
Tropism, cellular receptor, herpes simplex virus      26—27 28
Tropism, cellular receptor, human immunodeficiency virus      26 28
Tropism, cellular receptor, nonprotein receptors      28
Tropism, cellular receptor, viral attachment protein binding      25—26 28—29
Tropism, definition      12 25
Tropism, determinants      32s
Tropism, determinants, acid lability      33
Tropism, determinants, cellular receptors      30—32
Tropism, determinants, proteases      32 33
Tropism, determinants, temperature sensitivity      33
Tropism, determinants, transcriptional control      33—34
Tropism, lymphocytic choriomeningitis virus      32
Tropism, parvovirus B19      31—32
Tropism, poliovirus      30—31
Tropism, retrovirus      34—35
Tropism, variation and pathogenicity      35—37
Tumor necrosis factor (TNF), poxvirus viroceptors      112
Urine, shedding of viruses      22
Urogenital tract, viral entry      15
Vaccination, AIDS      See Human immunodeficiency virus
Vaccination, DNA vaccines      195—196
Vaccination, historical perspectives      189
Vaccination, immune induction principles      190s
Vaccination, inactivated viruses, denaturation      193
Vaccination, inactivated viruses, efficacy      193—194
Vaccination, inactivated viruses, recombinant proteins      194
Vaccination, inactivated viruses, safety      194
Vaccination, licensed human vaccines      190 192t 196
Vaccination, live attenuated virus, efficacy      190—192
Vaccination, live attenuated virus, safety      192—193
Vaccination, live attenuated virus, tropism      190
Vaccination, modalities, advantages and disadvantages      190 191t
Vaccination, modalities, overview      189—190 208
Vaccination, principles of immune induction relevant for efficacy      189—190
Vaccination, protective mechanisms, hepatitis B      200—203
Vaccination, protective mechanisms, polio      192t 196—198 197f 198f 198t
Vaccination, protective mechanisms, principles      196 197s 208
Vaccination, protective mechanisms, rabies      198—200
Vaccination, recombinant virus vaccines      194—195
Vaccination, replicons      195
Vaccinia virus, complement cascade interference      87 88f 112
Vaccinia virus, immunosuppression in mice      86t
Vaccinia virus, recombinant virus vaccines      195
VAP      See Viral attachment protein
Varicella-zoster virus (VZV), age effects on susceptibility      168
Varicella-zoster virus (VZV), latency      119—120
Viral attachment protein (VAP), cellular receptor binding      25—26 26f 28—29
Viral attachment protein (VAP), mutagenesis studies      36f
Viremia, acute viremia      18f
Viremia, blood to tissue pathway      19—20 20f
Viremia, cell associated viremia      17f 19 19t
Viremia, comparative pathogenesis of virulent and attenuated viruses      105
Viremia, human immunodeficiency virus      174—175
Viremia, phases      17
Viremia, plasma viremia      18
Viremia, potential and pathogenicity      105f 106f
Viremia, sources      18
Virulence, approaches to study      99—100
Virulence, attenuated variant virus selection, choice of viruses for virulence studies      104
Virulence, attenuated variant virus selection, cold-adapted variants      103—104 104t
Virulence, attenuated variant virus selection, monoclonal antibody-resistant viruses      104
Virulence, attenuated variant virus selection, mutagenized viruses      104
Virulence, attenuated variant virus selection, temperature-sensitive mutants      103
Virulence, cellular virulence genes, herpes simplex virus Fc receptors      112—113
Virulence, cellular virulence genes, overview      111—112
Virulence, cellular virulence genes, poxviruses      112
Virulence, comparative pathogenesis of virulent and attenuated viruses      0
Virulence, comparative pathogenesis of virulent and host immune response      108
Virulence, comparative pathogenesis of virulent and neural spread      105 106
Virulence, comparative pathogenesis of virulent and portal of entry      105
Virulence, comparative pathogenesis of virulent and target organ      106 107t
Virulence, comparative pathogenesis of virulent and tissue specificity      107—108
Virulence, comparative pathogenesis of virulent and viremia      105
Virulence, definition      99
Virulence, genetic determinants, bunyavirus      107f 109
Virulence, genetic determinants, molecular determination      111t
Virulence, genetic determinants, overview      108—109 109s
Virulence, genetic determinants, poliovirus      109—111
Virulence, genetic determinants, reovirus      109
Virulence, measures, case / infection ratio      100t 102
Virulence, measures, case fatality rate      101t 102
Virulence, measures, incubation period      100—101
Virulence, measures, Lesions      101 101f
Virulence, measures, plaque-forming unit assays      101 101f
Virulence, measures, symptoms      100
Virulence, passage in experimental manipulation, animals      102
Virulence, passage in experimental manipulation, cell culture      102
Virulence, passage in experimental manipulation, viral phenotype      102—103
Virulence, relative nature      100
Virus, origins of word      6s
VZV      See Varicella-zoster virus
West Nile virus (WNV), Flv and susceptibility in mice      16
West Nile virus (WNV), immunosuppression studies      117f
Western blot, antibody assay      60—61 61f
WNV      See West Nile virus
Yellow fever, history of study      6
Yellow fever, vaccine contamination      192—193 194f
1 2 3
blank
Реклама
blank
blank
HR
@Mail.ru
       © Электронная библиотека попечительского совета мехмата МГУ, 2004-2024
Электронная библиотека мехмата МГУ | Valid HTML 4.01! | Valid CSS! О проекте